| scholarly article | Q13442814 |
| P50 | author | Santiago Rodriguez de Córdoba | Q30759382 |
| Margarita López-Trascasa | Q54422019 | ||
| Pilar Sánchez-Corral | Q60506751 | ||
| Jorge Esparza-Gordillo | Q114324279 | ||
| Cynthia Abarrategui Garrido | Q114324280 | ||
| P2093 | author name string | Luis Carreras | |
| Elena Goicoechea de Jorge | |||
| P433 | issue | 11 | |
| P304 | page(s) | 1769-1775 | |
| P577 | publication date | 2006-01-18 | |
| P1433 | published in | Molecular Immunology | Q6895954 |
| P1476 | title | Insights into hemolytic uremic syndrome: segregation of three independent predisposition factors in a large, multiple affected pedigree | |
| P478 | volume | 43 |
| Q33568131 | A novel antibody against human properdin inhibits the alternative complement system and specifically detects properdin from blood samples. |
| Q26796453 | Advances and challenges in the management of complement-mediated thrombotic microangiopathies |
| Q56591965 | Atypical hemolytic uremic syndrome |
| Q21202864 | Atypical hemolytic uremic syndrome |
| Q33389773 | Atypical hemolytic uremic syndrome in the Tunisian population. |
| Q33419812 | Atypical hemolytic uremic syndrome post-kidney transplantation: two case reports and review of the literature |
| Q33392073 | Atypical hemolytic uremic syndrome: telling the difference between H and Y. |
| Q57702450 | Chapter 14 Hemolytic Uremic Syndrome/Thrombotic Thrombocytopenic Purpura |
| Q33406025 | Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype |
| Q90371957 | Common variants of fetal and maternal complement genes in preeclampsia: pregnancy specific complotype |
| Q33380163 | Complement and the atypical hemolytic uremic syndrome in children. |
| Q33408733 | Complement therapy in atypical haemolytic uraemic syndrome (aHUS). |
| Q33396792 | Complement-mediated injury and protection of endothelium: lessons from atypical haemolytic uraemic syndrome |
| Q33374215 | Complete factor H deficiency-associated atypical hemolytic uremic syndrome in a neonate |
| Q33377531 | Does hemolytic uremic syndrome differ from thrombotic thrombocytopenic purpura? |
| Q33398546 | Factor H and CFHR1 polymorphisms associated with atypical Haemolytic Uraemic Syndrome (aHUS) are differently expressed in Tunisian and in Caucasian populations |
| Q33417878 | Factors determining penetrance in familial atypical haemolytic uraemic syndrome |
| Q33404888 | Familial atypical hemolytic uremic syndrome: a review of its genetic and clinical aspects |
| Q33373674 | Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome |
| Q33389945 | Genetics and complement in atypical HUS. |
| Q33405246 | Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults |
| Q24685473 | Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome |
| Q54955566 | Germline mutations in the alternative pathway of complement predispose to HELLP syndrome. |
| Q57701679 | Hemolytic uremic syndrome |
| Q33377284 | Inherited complement regulatory protein deficiency predisposes to human disease in acute injury and chronic inflammatory statesthe examples of vascular damage in atypical hemolytic uremic syndrome and debris accumulation in age-related macular degen |
| Q33382404 | Lack of association between polymorphisms in C4b-binding protein and atypical haemolytic uraemic syndrome in the Spanish population |
| Q24650823 | Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome |
| Q33372897 | Modeling how CD46 deficiency predisposes to atypical hemolytic uremic syndrome |
| Q28263131 | Mutations in complement factor I as found in atypical hemolytic uremic syndrome lead to either altered secretion or altered function of factor I |
| Q28267924 | Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome |
| Q33392948 | New insights into postrenal transplant hemolytic uremic syndrome. |
| Q33430817 | Prevention and treatment of atypical haemolytic uremic syndrome after kidney transplantation |
| Q33403359 | STEC-HUS, atypical HUS and TTP are all diseases of complement activation |
| Q33382197 | Shiga toxin-2 results in renal tubular injury but not thrombotic microangiopathy in heterozygous factor H-deficient mice. |
| Q33375335 | Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains |
| Q33409714 | Targeted strategies in the prevention and management of atypical HUS recurrence after kidney transplantation. |
| Q36978838 | Testing the Activity of Complement Convertases in Serum/Plasma for Diagnosis of C4NeF-Mediated C3 Glomerulonephritis. |
| Q30377280 | The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome. |
| Q33378469 | The complement factor H R1210C mutation is associated with atypical hemolytic uremic syndrome |
| Q28300378 | The development of atypical hemolytic uremic syndrome depends on complement C5 |
| Q28272816 | The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models |
| Q35057817 | The local complement activation on vascular bed of patients with systemic sclerosis: a hypothesis-generating study |
| Q33422057 | The molecular and structural bases for the association of complement C3 mutations with atypical hemolytic uremic syndrome. |
| Q33402372 | Thrombotic microangiopathy and associated renal disorders |
| Q33377799 | Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H. |
| Q33378236 | Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals. |
| Q33377727 | Translational mini-review series on complement factor H: therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritis |
| Q33390080 | Triggering of atypical hemolytic uremic syndrome by influenza A (H1N1). |
| Q37322141 | Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations |
| Q38864097 | Utilizing complement evasion strategies to design complement-based antibacterial immunotherapeutics: Lessons from the pathogenic Neisseriae |
| Q33391370 | Variant-specific quantification of factor H in plasma identifies null alleles associated with atypical hemolytic uremic syndrome |
| Q37187461 | Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease |
| Q33390198 | aHUS caused by complement dysregulation: new therapies on the horizon |
Search more.